DK0625048T4 - Syntese af human procollagener og collagener i rekombinant DNA-systemer - Google Patents

Syntese af human procollagener og collagener i rekombinant DNA-systemer

Info

Publication number
DK0625048T4
DK0625048T4 DK92924122T DK92924122T DK0625048T4 DK 0625048 T4 DK0625048 T4 DK 0625048T4 DK 92924122 T DK92924122 T DK 92924122T DK 92924122 T DK92924122 T DK 92924122T DK 0625048 T4 DK0625048 T4 DK 0625048T4
Authority
DK
Denmark
Prior art keywords
collagen
collagens
synthesis
recombinant dna
human
Prior art date
Application number
DK92924122T
Other languages
Danish (da)
English (en)
Other versions
DK0625048T3 (da
Inventor
Darwin J Prockop
Andrzej Fertala
Aleksander Sieron
Kari I Kivirikko
Amy Geddis
Taina A Pihlajaniemi
Leena Ala-Kokko
Original Assignee
Fibrogen Inc
Univ Jefferson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25121036&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0625048(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fibrogen Inc, Univ Jefferson filed Critical Fibrogen Inc
Publication of DK0625048T3 publication Critical patent/DK0625048T3/da
Application granted granted Critical
Publication of DK0625048T4 publication Critical patent/DK0625048T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/11—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (1.14.11)
    • C12Y114/11002—Procollagen-proline dioxygenase (1.14.11.2), i.e. proline-hydroxylase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
DK92924122T 1991-10-23 1992-10-22 Syntese af human procollagener og collagener i rekombinant DNA-systemer DK0625048T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78089991A 1991-10-23 1991-10-23
PCT/US1992/009061 WO1993007889A1 (fr) 1991-10-23 1992-10-22 Synthese de procollagenes et de collagenes humains dans des systemes d'adn de recombinaison

Publications (2)

Publication Number Publication Date
DK0625048T3 DK0625048T3 (da) 2000-05-29
DK0625048T4 true DK0625048T4 (da) 2006-02-20

Family

ID=25121036

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92924122T DK0625048T4 (da) 1991-10-23 1992-10-22 Syntese af human procollagener og collagener i rekombinant DNA-systemer

Country Status (11)

Country Link
US (1) US5405757A (fr)
EP (2) EP0962529A1 (fr)
JP (2) JP3302017B2 (fr)
AT (1) ATE188253T1 (fr)
AU (2) AU680606B2 (fr)
CA (1) CA2121698C (fr)
DE (1) DE69230502T3 (fr)
DK (1) DK0625048T4 (fr)
ES (1) ES2143478T5 (fr)
GR (1) GR3033022T3 (fr)
WO (1) WO1993007889A1 (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020142391A1 (en) * 1991-06-12 2002-10-03 Kivirikko Kari I. Synthesis of human procollagens and collagens in recombinant DNA systems
US5667839A (en) * 1993-01-28 1997-09-16 Collagen Corporation Human recombinant collagen in the milk of transgenic animals
US6653450B1 (en) * 1993-01-28 2003-11-25 Cohesion Technologies, Inc. Mutated recombinant collagens
EP0676412A4 (fr) * 1993-10-25 1998-02-04 Teijin Ltd Chondrocalcine humaine purifiee, procede de production et utilisation de ce produit.
EP0759932A4 (fr) * 1994-05-11 1997-11-19 Organo Genesis Inc Collagene obtenu a partir de cultures cellulaires
US6713662B1 (en) * 1994-07-27 2004-03-30 Pharming Intellectual Property B.V. Production of collagen in the milk of transgenic mammals
AU6764396A (en) 1995-08-08 1997-03-05 Thomas Jefferson University Recombinant c-proteinase and processes, methods and uses thereof
ATE242325T1 (de) * 1995-08-31 2003-06-15 Univ Manchester Procollagene
WO1997014431A1 (fr) * 1995-10-20 1997-04-24 Collagen Corporation Production de procollagene recombinant dans la levure
US5773248A (en) * 1995-11-13 1998-06-30 Uab Research Foundation Nucleic acid encoding a human α3(IX) collagen protein and method of producing the protein recombinantly
BR9611547A (pt) * 1995-11-13 1999-06-15 Fibrogen Inc Proteína de fusão processos para produzir proteína de fusão humana recombinante e colágeno tipo ix humano recombinante
WO1997038710A1 (fr) * 1996-04-12 1997-10-23 Fibrogen, Inc. Synthese de procollagenes et de collagenes humains dans des systemes d'adn de recombinaison
US5856308A (en) * 1996-09-27 1999-01-05 Haemacure Corporation Artificial collagen
AU780813B2 (en) * 1996-10-29 2005-04-21 Commonwealth Scientific And Industrial Research Organisation Stable expression of triple helical proteins
WO1998018918A1 (fr) * 1996-10-29 1998-05-07 Commonwealth Scientific And Industrial Research Organisation Expression stable de proteines a helice triple
AUPO331096A0 (en) * 1996-10-29 1996-11-21 Commonwealth Scientific And Industrial Research Organisation Collagen products
FR2757874B1 (fr) * 1996-12-17 2003-04-25 Biocem Collagenes recombinants et proteines derivees produits par les plantes, leurs procedes d'obtention et leurs utilisations
GB9704305D0 (en) * 1997-03-01 1997-04-23 Univ Manchester Procollagen assembly
NL1007908C2 (nl) * 1997-12-24 1999-06-25 Fuji Photo Film Bv Zilverhalide-emulsies met recombinant collageen die geschikt zijn voor fotografische toediening alsmede de bereiding daarvan.
US6150081A (en) 1997-12-24 2000-11-21 Fuji Photo Film B.V. Silver halide emulsions with recombinant collagen suitable for photographic application and also the preparation thereof
DE19812713A1 (de) * 1998-03-24 1999-09-30 Merck Patent Gmbh Verfahren zur Herstellung von mineralisierten Kollagenfibrillen und deren Verwendung als Knochenersatzwerkstoff
JP2000125872A (ja) * 1998-09-07 2000-05-09 Terumo Corp 三量体キメラタンパク質およびキメラタンパク質を含有するコラーゲンマトリックス
HK1046004B (en) * 1999-11-12 2013-11-08 Fibrogen, Inc. Recombinant gelatins
BR0015507A (pt) * 1999-11-12 2002-10-22 Fibrogen Inc Gelatinas e colágenos animais
AU2003221582A1 (en) * 2002-05-03 2003-11-17 Millenium Biologix Inc. Connective tissue stimulating peptides
KR20050042819A (ko) 2002-09-13 2005-05-10 오큘라 사이언시즈, 인크. 시력 개선 장치 및 방법
GB0309064D0 (en) 2003-04-22 2003-05-28 Univ Manchester Modified peptides and their uses
CN1972643A (zh) 2004-05-20 2007-05-30 库柏维景公司 用于提高视力的角膜覆盖物和波前像差矫正
AU2012200573B2 (en) * 2005-03-31 2013-11-07 Fuso Pharmaceutical Industries, Ltd. "Process for production of protein having triple-helical structure"
WO2006106970A1 (fr) * 2005-03-31 2006-10-12 Fuso Pharmaceutical Industries, Ltd. Procede pour la production d’une proteine ayant une structure tri-helicoïdale
EP3015101B1 (fr) 2005-10-03 2019-08-21 PINSKY, Mark A. Liposomes non-phospholipides contenant d'acide hyaluronique
US20080081353A1 (en) * 2006-09-29 2008-04-03 Universite Laval Production of recombinant human collagen
ES2710498T3 (es) 2007-12-26 2019-04-25 Mark A Pinsky Formulaciones de colágeno para la mejora del cuidado de la piel
EP2288376B1 (fr) * 2008-04-18 2016-01-13 Collplant Ltd. Procédés de génération et d utilisation de procollagène
CN106243229B (zh) 2008-12-22 2019-09-06 国立大学法人北海道大学 具有三螺旋结构的蛋白质物质及其制造方法
US9040484B2 (en) 2011-04-26 2015-05-26 The Board Of Trustees Of The Leland Stanford Junior University Production and delivery of a stable collagen
US20140066379A1 (en) * 2012-08-30 2014-03-06 Body Organ Biomedical Corp. Recombinant vector, transgenic fish egg using the same and biomaterial using the same
FR3033697B1 (fr) * 2015-03-17 2020-03-27 Universite Pierre Et Marie Curie (Paris 6) Suspensions de collagene injectables, leur procede de preparation et leurs utilisations, notamment pour la formation de matrices denses de collagene
CA3140144A1 (fr) * 2019-05-14 2020-11-19 Provenance Bio, Llc Expression de proteines modifiees dans un peroxisome
KR102135976B1 (ko) * 2019-10-24 2020-07-20 주식회사 에이바이오테크 콜라겐 합성 촉진 활성을 갖는 펩타이드 및 이를 이용한 방법
DE102021202830A1 (de) 2021-03-23 2022-09-29 Gelita Ag Rekombinantes Typ II-Kollagen zur therapeutischen Verwendung
EP4504761B1 (fr) 2022-04-04 2026-02-04 SwiftPharma BV Protéines recombinées de collagène renforcées par la soie d'araignée, produites dans des plantes et leur utilisation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4645748A (en) * 1985-02-01 1987-02-24 Charles Hurwitz Protein which is characteristic of rheumatoid arthritis
US4840793A (en) * 1987-06-11 1989-06-20 Dana-Farber Cancer Institute Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
US5147638A (en) * 1988-12-30 1992-09-15 Oklahoma Medical Research Foundation Inhibition of tumor growth by blockade of the protein C system
US5045449A (en) 1989-06-14 1991-09-03 Thomas Jefferson University Methods of detecting a genetic predisposition for vascular aneurysms
US5136021A (en) * 1990-02-27 1992-08-04 Health Research, Inc. TNF-inhibitory protein and a method of production

Also Published As

Publication number Publication date
ES2143478T3 (es) 2000-05-16
GR3033022T3 (en) 2000-08-31
DK0625048T3 (da) 2000-05-29
JP3302017B2 (ja) 2002-07-15
EP0625048A4 (fr) 1995-04-05
AU4441497A (en) 1998-02-12
EP0625048A1 (fr) 1994-11-23
US5405757A (en) 1995-04-11
JP2002255999A (ja) 2002-09-11
ES2143478T5 (es) 2006-05-16
DE69230502T2 (de) 2000-08-10
ATE188253T1 (de) 2000-01-15
DE69230502D1 (de) 2000-02-03
EP0962529A1 (fr) 1999-12-08
HK1010334A1 (en) 1999-06-17
CA2121698C (fr) 2010-05-18
AU680606B2 (en) 1997-08-07
CA2121698A1 (fr) 1993-04-29
DE69230502T3 (de) 2006-05-24
WO1993007889A1 (fr) 1993-04-29
AU3055592A (en) 1993-05-21
JPH07501939A (ja) 1995-03-02
EP0625048B1 (fr) 1999-12-29
EP0625048B2 (fr) 2005-10-26

Similar Documents

Publication Publication Date Title
DK0625048T3 (da) Syntese af humane procollagener og collagener i rekombinant DNA-systemer
NO954525L (no) BMP-10 sammensetninger
DE69333731D1 (de) Glialmitogene faktoren, ihre herstellung und verwendung
DE69228118D1 (de) Bmp-9 zusammensetzungen
ES2128330T3 (es) Material para la substitucion de huesos con factores de crecimiento de fibroblastos.
DE69128893D1 (de) Genetische veränderung von endothelzellen
DE69528058D1 (de) Bmp-9 zusammensetzungen
DE69722681D1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen darmerkrankungen
EP0846262A4 (fr) Imagerie et spectroscopie des tissus, basees sur la duree de vie de la fluorescence et autres supports programmables
DE59302553D1 (de) Implantat als Knochenersatz
DE69637256D1 (de) Synthese von Methoxynukleoside und enzymatische Nukleisäure Moleküle
DK1690874T3 (da) BMP-12, BMP-13 og sene-inducerende sammensætninger deraf
ATE238417T1 (de) Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung
SE9304093D0 (sv) Anordning för att befrämja bentillväxt
DE59611411D1 (de) Verwendung von alpha 1l-agonisten zur behandlung der harninkontinenz
ATE120738T1 (de) 2,4-diamino-pyrimidin-3-oxid-derivate und deren verwendung bei der behandlung und zur verhütung von haarfall.
ATE217782T1 (de) Kosmetische zusammensetzung enthaltend ein anionisches polymer und ein acrylisches terpolymer und verwendung dieser zusammensetzung zur behandlung von keratinfasern
DE69630955T2 (de) Immortalisierung bzw. desimmortalisierung von zellen
ATE256740T1 (de) Menschliches sdf-5 protein und diesbezügliche zusammensetzungen
DE69530933D1 (de) Verwendung von 5-(tetradecyloxy)-2-furan carbonsäure für die behandlung von alzheimer krankheit oder psychosis
ATE209027T1 (de) Kosmetische zusammensetzung enthaltend ein polyorganosiloxan und ein acrylterpolymer und verwendung dieser zusammensetzung zur behandlung von keratinmaterial
DK1028744T3 (da) Neuronale anvendelser af BMP-11
BR0014183A (pt) Composições farmaceuticas e metodos de uso de proteìna relacionada frizzled secretada
ATE79031T1 (de) Verwendung von ketonderivaten zur behandlung von depressionen.
ATE221763T1 (de) Die verwendung von glyceryltriacetat zur behandlung von onychomykosen